UBS AM’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $202K | Buy |
6,450
+3,550
| +122% | +$111K | ﹤0.01% | 2562 |
|
|
2025
Q1 | $86K | Buy |
+2,900
| New | +$86K | ﹤0.01% | 2602 |
|
|
2024
Q4 | – | Sell |
-92,257
| Closed | -$2.87M | – | 2709 |
|
|
2024
Q3 | $2.87M | Buy |
92,257
+91,033
| +7,437% | +$2.83M | ﹤0.01% | 1845 |
|
|
2024
Q2 | $41.5K | Sell |
1,224
-92,893
| -99% | -$3.15M | ﹤0.01% | 2784 |
|
|
2024
Q1 | $6.12M | Sell |
94,117
-11,568
| -11% | -$752K | ﹤0.01% | 1170 |
|
|
2023
Q4 | $7.22M | Sell |
105,685
-1,577
| -1% | -$108K | ﹤0.01% | 1110 |
|
|
2023
Q3 | $5.57M | Sell |
107,262
-4,238
| -4% | -$220K | ﹤0.01% | 1166 |
|
|
2023
Q2 | $5.51M | Hold |
111,500
| – | – | ﹤0.01% | 1187 |
|
|
2023
Q1 | $5.51M | Sell |
111,500
-1,400
| -1% | -$69.2K | ﹤0.01% | 1187 |
|
|
2022
Q4 | $6.44M | Buy |
112,900
+34,438
| +44% | +$1.97M | ﹤0.01% | 1088 |
|
|
2022
Q3 | $3.68M | Buy |
+78,462
| New | +$3.68M | ﹤0.01% | 1308 |
|